John Milton
Chief Tech/Sci/R&D Officer at OXFORD NANOPORE TECHNOLOGIES PLC
Profile
Presently, John Milton holds the position of Chief Scientific Officer of Oxford Nanopore Technologies Ltd. In the past he was Manager of Xenova Group Plc, Senior Director-Research & Development at Solexa Ltd. and Principal at Glaxo Wellcome Plc. Dr. Milton received a doctorate from The University of Liverpool.
John Milton active positions
Companies | Position | Start |
---|---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Chief Tech/Sci/R&D Officer | - |
Former positions of John Milton
Companies | Position | End |
---|---|---|
Solexa Ltd.
Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Chief Tech/Sci/R&D Officer | 01/01/2007 |
Glaxo Wellcome Plc | Corporate Officer/Principal | - |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | - |
Training of John Milton
The University of Liverpool | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
Private companies | 3 |
---|---|
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
Glaxo Wellcome Plc | Health Technology |
Solexa Ltd.
Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Health Technology |
- Stock Market
- Insiders
- John Milton